Skip to main content
Erschienen in: Malaria Journal 1/2010

Open Access 01.12.2010 | Research

Determinants of compliance with malaria chemoprophylaxis among French soldiers during missions in inter-tropical Africa

verfasst von: Noémie Resseguier, Vanessa Machault, Lénaick Ollivier, Eve Orlandi-Pradines, Gaetan Texier, Bruno Pradines, Jean Gaudart, Alain Buguet, Catherine Tourette-Turgis, Christophe Rogier

Erschienen in: Malaria Journal | Ausgabe 1/2010

Abstract

Background

The effectiveness of malaria chemoprophylaxis is limited by the lack of compliance whose determinants are not well known.

Methods

The compliance with malaria chemoprophylaxis has been estimated and analysed by validated questionnaires administered before and after the short-term missions (about four months) in five tropical African countries of 2,093 French soldiers from 19 military companies involved in a prospective cohort study. "Correct compliance" was defined as "no missed doses" of daily drug intake during the entire mission and was analysed using multiple mixed-effect logistic regression model.

Results

The averaged prevalence rate of correct compliance was 46.2%, ranging from 9.6%to 76.6% according to the companies. Incorrect compliance was significantly associated with eveningness (p = 0.028), a medical history of clinical malaria (p < 0.001) and a perceived mosquito attractiveness inferior or superior to the others (p < 0.007). Correct compliance was significantly associated with the systematic use of protective measures against mosquito bites (p < 0.001), the type of military operations (combat vs. training activities, p < 0.001) and other individual factors (p < 0.05).

Conclusions

The identification of circumstances and profiles of persons at higher risk of lack of compliance would pave the way to specifically targeted strategies aimed to improve compliance with malaria chemoprophylaxis and, therefore, its effectiveness.
Hinweise

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

NR performed the statistical analysis and wrote the article. VM participated significantly in the data management. LO, EOP and GT participated significantly in the data management and the conception of the questionnaires. JG participated in the statistical analysis. BP, CTT and AB contributed significantly in the preparation of the study. CR conceived the study, took part in the analysis of the data and the discussion and wrote the article. The final version of the manuscript was seen and approved by all authors.

Background

Non-immune civilians and military personnel traveling in malaria-endemic areas are at risk of getting malaria and may become clinically ill during or after their travel. Approximately 25-30 million travellers from non-tropical regions visit malaria-endemic countries annually, and about 30,000 cases of travel-associated clinical malaria occur each year [1]. In the UK, the incidence of imported clinical malaria among civilian travellers visiting West Africa varied from 196 cases to 52 cases/1,000 traveller-years between 2003 and 2006 [2]. In a Swedish survey, conducted from 1997 to 2003, the annual incidence rate of clinical malaria was 240, 302 and 357 per 100,000 travellers to East Africa, West Africa and Central Africa, respectively [3]. In a cohort of the French general population, followed from 1994 to 1998, the incidence of malaria imported from endemic areas was 435 cases per 100,000 trips, corresponding to 178 cases per 1,000 traveller-years [4]. In the French Armed Forces, the annual incidence rate was 14 per 1,000 person-years in 2006, and half of the 558 cases occurred after the patients returned to France. Among French soldiers serving in Côte d'Ivoire between 1998 and 2006, the annual malaria incidence rate ranged from 27.5 to 294.7 cases per 1,000 person-years; the maximum rate resulted from an epidemic among the troops during fighting operations in 2002. The risk of malaria for travellers varies notably between endemic areas and periods of exposure [5].
Malaria is an important threat to tourists, soldiers and employees travelling or working in endemic areas, particularly because of the potentially rapid onset of infection and the severity of the disease. Non-immune travellers should be protected from malaria by chemoprophylaxis and prophylactic measures against mosquito bites, including insecticide-impregnated bed nets (IIBN), repellents and insecticide-treated long-sleeved clothes and pants. In malaria-endemic areas, the use of most of these prophylactic measures is mandatory for non-immune soldiers of Western armies or for non-immune employees of most major international groups. The resistance of Plasmodium falciparum to most anti-malarial drugs and the resistance of Anopheles to insecticides may limit the efficacy of these prophylactic measures. Chemoprophylaxis is a key component of malaria prevention because none of the vector protection measures totally avoid mosquito bites during night activities. However, the effectiveness of chemoprophylaxis is limited by lack of compliance with drug intake, even if the regimen is adapted to the chemosusceptibility of P. falciparum[6, 7].
Many clinical malaria cases and outbreaks [811] have been attributed to suboptimal compliance with chemoprophylaxis [12, 13], including among military personnel [1416]. In a cohort study, lack of compliance with prophylactic measures was the second most important factor that determined the malaria incidence rate among non-immune travellers [5].
It is generally acknowledged that the lack of compliance with medications is unrelated to the lack of symptoms or risk perception. In fact, compliance determinants are not well known, especially for chronic diseases, such as HIV infection [17, 18], diabetes [19, 20], psychosis [21, 22], tuberculosis [23, 24], or for malaria chemoprophylaxis [2528]. A better understanding of the determinants of the compliance with malaria chemoprophylaxis could pave the way for the improvement of its effectiveness and for the development of interventions aimed at enhancing compliance.
The objective of the present study was to identify the determinants of compliance with malaria chemoprophylaxis among French soldiers on a short-term mission in malaria-endemic areas of tropical Africa.

Methods

Study design and inclusion criteria

The present study was part of a larger prospective cohort study on the risks of vector-borne diseases among French soldiers carried out between February 2004 and September 2007. The study comprised 19 French military companies (100 to 150 individuals per company) serving a short-term mission (about four months) in five tropical African countries: eight companies in Côte d'Ivoire, four in Gabon, three in Chad, two in Central African Republic and two in Senegal. The soldiers were required to take chemoprophylaxis and apply protective measures against mosquitoes. These companies were selected to represent the various conditions that French soldiers experience in Africa. All members of the companies designated for the mission were eligible for the study and were invited to participate. Soldiers absent from the regiment on the dates of the surveys or who left the company between the survey and the departure or during the mission were excluded from the analysis.
The protocol was approved by the ethical committee Marseille II (Advice no. 02/81, 12/13/2002). The informed consent of each participant was obtained at the beginning of the study after a thorough explanation of its purpose.
Two self-administered questionnaires containing behavioural items were filled out by each soldier and validated by a member of the research team. The first survey was administered no earlier than 15 days before their departure, and the second was completed no later than 15 days after their return.

Data collection

The dependant variable was the level of compliance with malaria chemoprophylaxis during the mission as assessed retrospectively by the return questionnaire. "Correct" compliance was defined as "No missed doses" of daily drug intake during the entire mission, while "incorrect" compliance was defined as one of the three other possible responses: "Less than one missed dose per month," "One or more missed doses per month, but less than one missed dose per week" or "One or more missed doses per week".
Independent variables that were considered potential determinants of compliance were recorded for each soldier either upon departure or return. These variables were related to individual characteristics or to the particular settings of the mission, as described below.
Variables relative to the mission were the dates of departure and return, country and mission type, such asmilitary operation or training. Demographic and behavioural variables were age, gender, rank, usual morningness and eveningness (as determined using the reduced Horne and Östberg morningness-eveningness questionnaire [2931]), wake and sleep times during the mission, previous travel overseas or other malaria-endemic areas and tobacco consumption. Morningness and eveningness were used to determine the chronotype, i.e. the circadian rhythm of the soldiers: morning people waking up early and being more alert in the first part of the day, evening people being more alert in the late evening hours and preferring to go to bed late.
Other variables pertained to the occurrence of important familial events during the mission (e.g., birth of a child, illness or death of a relative or friend, or separation or announcement of a divorce). Other variables included the subjective perceived risk level during the mission associated with i) a dangerous situation, ii) the individual likelihood of acquiring clinical malaria, and iii) the severity of disease if malaria were contracted.
Variables related to protective measures against vectors included the condition of the received IIBN and the use of each protective measure designated for each type of activity during the mission (guard, operation out of the military camp, free time, and time in the military camp). A global score was calculated by combining the frequency of use of each antivectorial measure during each activity with the time spent in each activity. Moreover, a global variable summarizing the use of all anti-vectorial protective measures (including repellents, long sleeved clothes and IIBN) was constructed.
Independent variables relative to the chemoprophylaxis were the drug itself (either doxycycline or chloroquine-proguanil combination with once-daily dosages), tolerance and usual time schedules of intake.
The variables incorporating medical antecedents were allergy to insect bites, usual cutaneous response to mosquito bites and medical history of malaria, leishmaniasis or dengue fever (i.e., themain vector-borne diseases experienced by the French Forces). Variables pertaining to medical events that occurred during the mission included clinical malaria, non-malarial fever, diarrhoea, boil, other severe infectious disease (i.e., medical issues that required hospitalization or drug treatment for one month or more), perceived frequency of mosquito bites and perceived personal mosquito attractiveness.

Statistical methods

Data were recorded using EpiDATA v3.0 and were checked for consistency before statistical analysis using STATA 9.0 (StataCorpLP, College Station, TX, USA). Only participants who completed both questionnaires were considered for statistical analysis. Missing values affected less than 1% of the participants and were replaced using the single imputation method. When a question was not asked to one or more companies, the responses were coded as missing data for those companies.
The confidence interval of correct compliance with malaria chemoprophylaxis was estimated by taking into account the clustered design of the study using the svy commands under STATA 9.0. Compliance with chemoprophylaxis was analysed as a dependant variable according to individual and company characteristics using a random effect mixed logistic regression model. The model was designed to take into account the intra-company correlations that could exist due to the sampling design (company effect as random effect). The logistic model was also adjusted using a generalized estimating equations (GEE) approach. Random effect and GEE regression models allow the estimation of company-specific and population-averaged effects, respectively [32].
First, a descriptive analysis of the independent variables was performed. A bivariate analysis was then conducted by entering each independent variable in a logistic regression model. Variables were retained for the multivariate analysis when their effect had a p-value less than 0.25 [33]. A backward stepwise selection procedure was applied to retain the significant (p < 0.05) independent variables and their interactions in the final model. The statistical quality of the final model was assessed by looking at the adequacy between observed and predicted probabilities of correct compliance.

Results

Study population

Of 2,901 eligible soldiers from 19 companies, 808 were excluded because they did not complete both questionnaires, leaving a sample of 2,093 subjects. The most common reason for not completing the questionnaires was the absence of the subject from the regiment at the time of the survey (because of holidays, training or a mission). Some soldiers who had planned to deploy to Africa and completed the first questionnaire did not travel and were replaced by others who had not completed the survey. Some soldiers returned to France before the rest of their company or were transferred to another regiment and were not present at the time of the second survey. The rate of refusal to participate in the study was lower than 5%.
The descriptive characteristics of the companies are summarized in Table 1. A total of 17 clinical malaria cases occurred during the mission among the 2,093 soldiers, which corresponds to an incidence rate of 0.81 cases per 100 soldier-missions (2.37 cases per 100 soldier-years).
Table 1
Characteristics of the companies
Comp
Country of the mission
Mission dates (MM/YY)
Type of the mission
Nb of soldiers
Nb of men
Age: median (25%-75% quantile)
Nb of soldiers with correct compliance
Nb of clinical malaria attacks
  
Start
End
      
1
Ivory Coast
02/04
06/04
Operation
144
143
26 (25 - 29)
51 (35.4%)
3
2
CAR
02/05
05/05
Operation
115
115
26 (23 - 29)
53 (46.1%)
2
3
Ivory Coast
02/05
05/05
Operation
108
108
22 (21 - 26)
70 (64.8%)
1
4
Ivory Coast
02/05
05/05
Operation
95
95
22 (20 - 24)
55 (57.9%)
0
5
Ivory Coast
02/05
05/05
Operation
73
72
23 (22 - 26)
38 (52.1%)
1
6
Senegal
06/05
09/05
Training
133
132
26 (22 - 30)
16 (12%)
0
7
Ivory Coast
06/08
09/05
Operation
84
84
25 (22 - 28.5)
54 (64.3%)
0
8
Ivory Coast
06/08
09/05
Operation
72
66
24 (22.5 - 28.5)
44 (61.1%)
1
9
Chad
10/05
01/06
Operation
134
130
24 (21 - 27)
85 (63.4%)
2
10
Senegal
02/06
05/06
Training
102
100
25 (22 - 28)
16 (15.7%)
0
11
Chad
02/06
05/06
Operation
83
78
25 (22 - 29)
44 (53.0%)
1
12
Gabon
07/06
11/06
Training
94
94
23.5 (21- 29)
9 (9.6%)
1
13
Gabon
07/06
11/06
Training
114
114
24 (21 - 29)
12 (10.5%)
2
14
Chad
06/06
09/06
Operation
189
185
24 (21 - 29)
130 (68.8%)
0
15
Gabon
12/06
04/07
Training
125
123
25 (22 - 30)
49 (39.2%)
0
16
Gabon
12/06
04/07
Training
135
133
24 (22 - 31)
38 (28.1%)
1
17
CAR
06/07
09/07
Operation
102
102
23 (20 - 29)
78 (76.5%)
0
18
Ivory Coast
06/07
09/07
Operation
94
92
22 (20 - 25)
72 (76.6%)
1
19
Ivory Coast
06/07
09/07
Operation
97
96
23 (21 - 28)
53 (54.6%)
1
Total
 
02/04
09/07
 
2093
2062
24 (21 - 28)
967 (46.2%)
17
Comp: Company; Nb: Number; CAR: Central African Republic

Compliance with the chemoprophylaxis

Assessment of compliance level with chemoprophylaxis was based on the self-reported occurrences of daily medication doses missed during the mission. "No missed doses" was indicated by 967 out of 2,093 soldiers, or 46.2% "correct" compliance. Between companies, the lowest proportion of correct compliance was 9.6%, and the highest was 76.6%.
Among the other three responses corresponding to incorrect compliance, "less than one missed dose per month" was declared by 637 soldiers (30.4%); "one or more missed doses per month but less than one missed dose per week" was declared by 298 soldiers (14.2%); and "one or more missed doses per week" was declared by 191 soldiers (9.1%).
The frequency of correct compliance was calculated according tothe following: variables related to the mission, demographics and behavioral characteristics; the occurrence of particular events during the mission and the perception of risks; use of anti-mosquito protective measures; use of malaria chemoprophylaxis; and medical history and occurrence of medical events during the mission. These data are shown in Tables 2, 3, 4, 5 and 6, respectively.
Table 2
Variables related to the mission as well as the demographics and behavioral characteristics
 
N
N-CC
Prevalence of CC
   
% (95% CI)
OR
95% CI
p value
Type of the mission
     
< 0.001
   Training
703
140
19.9 (10.0 - 29.8)
1
  
   Military operation
1390
827
59.5 (51.8 - 67.2)
6.17
3.36 - 11.32
 
Duration of the mission (mo)
   
0.81
0.61 - 1.07
0.1313
Age
     
0.2150
   18 - 24 y.
1071
503
47.0 (34.9 - 59.1)
1
  
   25 y. and more
1022
464
45.4 (34.115 - 56.4)
1.11
0.94 - 1.30
 
Gender
     
0.3667
   Men
2062
953
46.2 (34.8 - 57.6)
1
  
   Women
31
14
45.2 (29.6 - 60.7)
0.74
0.38 - 1.4
 
Rank
     
0.0329
   JRs - NCOs
1610
728
45.2 (33.9 - 56.6)
1
  
   Os - WOs
483
239
49.5 (37.7 - 61.3)
1.22
1.02 - 1.47
 
Favorite time for activities
     
0.0097
   Morning type
531
252
47.5 (35.0 - 59.9)
1
  
   Intermediate type
1248
585
46.9 (35.3 - 58.5)
0.83
0.69 - 1.00
 
   Evening type
314
130
41.4 (30.1 - 52.7)
0.68
0.52 - 0.87
 
Bedtime during the mission
     
0.0033
   Before or at midnight
1607
778
48.4 (35.7 - 61.1)
1
  
   After midnight
342
138
40.4 (30.0 - 50.7)
0.69
0.55 - 0.86
 
   NA (Company 1)
144
51
35.4 (27.5 - 43.3)
0.57
0.09 - 3.56
 
Previous overseas travel
     
0.1778
   No
435
244
56.1 (44.7 - 67.5)
1
  
   Yes
1658
723
43.6 (32.3 - 54.9)
0.87
0.72 - 1.06
 
Tobacco consumption
     
0.0420
   Nonsmoker
934
451
48.3 (36.2 - 60.4)
1
  
   Smoker 1-20 cig/d.
903
406
45.0 (33.0 - 56.9)
0.86
0.73 - 1.02
 
   Smoker >20 cig/d.
256
110
43.0 (32.3 - 53.7)
0.75
0.58- 0.96
 
N: Number of subjects; CC: Subjects with correct compliance; NA: Not Available
JRs - NCOs: junior ranks and noncommissioned officers; Os - WOs: officers and warrant officers; Cig/d.: cigarettes per day.
Table 3
Variables related to the occurrence of events during the mission and the perception of risks
 
N
N-CC
Prevalence of CC
   
% (95% CI)
OR
95% CI
p value
Birth of a child
     
0.1168
   No
2040
941
46.1 (35.0 - 57.3)
1
  
   Yes
53
26
49.1 (29.4 - 68.7)
1.49
0.91 - 2.46
 
Death of a relative or a friend
     
0.5877
   No
2004
928
46.3 (35.1 - 57.5)
1
  
   Yes
89
39
43.8 (27.1 - 60.6)
1.11
0.76 - 1.63
 
Disease of a relative or a friend
     
0.9812
   No
1996
926
46.4 (35.0 - 57.8)
1
  
   Yes
97
41
42.3 (30.3 - 54.2)
1
0.69 - 1.44
 
Announcement of a separation or a divorce
     
0.2850
   No
2048
943
46.0 (34.7 - 57.4)
1
  
   Yes
45
24
53.3 (32.4 - 74.3)
1.34
0.78 - 2.29
 
Perception of a dangerous situation
     
0.2358
   No
2041
947
46.4 (35.0 - 57.8)
1
  
   Yes
52
20
38.5 (23.8 - 53.1)
0.73
0.44 - 1.23
 
Perception of personal malaria risk compared to other soldiers
     
0.4728
   Inferior
280
132
47.1 (34.3 - 60.0)
1
  
   Equivalent
1388
644
46.4 (34.3 - 58.5)
1.04
0.82 - 1.32
 
   Superior
425
191
45.0 (33.1 - 56.8)
0.92
0.70 - 1.21
 
Perception of the severity of malaria
     
0.0295
   Not severe
254
136
53.5 (42.7 - 64.4)
1.3
1.02 - 1.66
 
   Mildly severe
1473
654
44.4 (32.4 - 56.4)
1
  
   Very severe
366
177
48.4 (35.1 - 61.6)
1.22
0.99 - 1.51
 
Perceived mosquito attractiveness compared to other soldiers
     
0.0024
   Inferior to the others
608
275
45.2 (32.1 - 58.3)
0.77
0.64 - 0.93
 
   Equivalent to the others
998
490
49.1 (38.3 - 59.9)
1
  
   Superior to the others
487
202
41.5 (29.0 - 53.9)
0.75
0.61 - 0.91
 
N: Number of subjects; CC: Subjects with correct compliance
Table 4
Variables related to adherence to anti-mosquito protective measures
 
N
N-CC
Prevalence of CC
   
% (95% CI)
OR
95% CI
p value
Condition of the received bed net
     
0.0502
   Bad condition
736
338
45.9 (32.3 - 59.5)
1
  
   Good condition
1145
543
47.4 (36.0 - 58.9)
1.19
1.00 - 1.42
 
   NA: Company 1 or no net received
212
86
40.6 (25.9 - 55.2)
-
-
 
Use of repellents before bedtime
     
0.0144
   Not always
2019
919
45.5 (34.4 - 56.6)
1
  
   Always
74
48
64.9 (45.0 - 84.8)
1.73
1.11 - 2.67
 
Use of insecticides for clothes before bedtime
     
0.0592
   Not always
1922
894
46.5 (34.5 - 58.5)
1
  
   Always
27
22
81.5 (71.4 - 91.6)
2.46
1.15 - 5.28
 
   NA (Company 1)
144
51
35.4 (27.5 - 43.3)
0.62
0.10 - 3.80
 
Long clothes worn before bedtime
     
0.0026
   Not always
1025
384
37.5 (22.7 - 52.2)
1
  
   Always
1068
583
54.6 (46.4 - 62.8)
1.33
1.11 - 1.61
 
Use of a bed net during sleep
     
< 0.0001
   Not always
981
411
41.9 (26.1 - 57.7)
1
  
   Always
1112
566
50.0 (37.9 - 62.1)
1.57
1.28 - 1.94
 
Systematic use of protective measures: long clothes, repellents, and bed net
     
< 0.0001
   No one
653
249
38.1 (21.4 - 54.9)
1
  
   One of them
671
277
41.3 (26.8 - 55.8)
1.31
1.05 - 1.63
 
   Two or three of them
769
441
57.4 (48.0 - 66.7)
2.03
1.56 - 2.65
 
N: Number of subjects; CC: Subjects with correct compliance; NA: Not Available
Table 5
Variables related to the chemoprophylaxis
 
N
N-CC
Prevalence of CC
   
% (95% CI)
OR
95% CI
p value
Drug prescribed
     
0.0592
   Chloroquine - proguanil
409
259
63.3 (55.3 - 71.4)
1
  
   Doxycycline
1675
701
41.9 (29.9 - 53.8)
0.65
0.34 - 1.26
 
   Mefloquine or other
9
7
77. 8 (46.9 - 100.0)
2.9
0.58 - 14.44
 
Tolerance to the intake
     
0.1077
   Rather bad to very bad
173
64
37.0 (18.4 - 55.6)
1
  
   Rather good
1010
442
43.8 (32.7 - 54.9)
1
0.74 - 1.35
 
   Very good
910
461
50.7 (39.7 - 61.7)
1.19
0.88 - 1.61
 
Regularity of the day time of the intake
     
0.0419
   Rather at the same time
1622
826
50.9 (40.1 - 61.8)
1
  
   Rather at different times
327
90
27.5 (14.9 - 40.2)
0.75
0.59 - 0.94
 
   NA (Company 1)
144
51
35.4 (27.5 - 43.3)
0.58
0.10 - 3.44
 
N: Number of subjects; CC: Subjects with correct compliance; NA: Not Available
Table 6
Variables related to the medical history of infectious diseases or the occurrence of diseases during the mission
 
N
N-CC
Prevalence of CC
   
% (95% CI)
OR
95% CI
p value
Medical history of malaria
     
0.0002
   No
1870
902
48.2 (37.0 - 59.5)
1
  
   Yes
180
50
27.8 (17.2 - 38.4)
0.59
0.44 - 0.79
 
   Does not know
43
15
34.9 (18.6 - 51.1)
0.51
0.28 - 0.91
 
Medical history of dengue fever
     
0.0625
   No
1961
921
46.97 (35.7 - 58.3)
1
  
   Yes
83
26
31.32 (19.3 - 43.3)
0.66
0.44 - 1.00
 
   Does not know
49
20
40.82 (22.0 - 59.7)
0.69
0.40 - 1.16
 
Occurrence of a disease during the mission
     
0.1223
   No
1177
540
45.9 (34.2 - 57.6)
1
  
   Yes
916
427
46.6 (34.5 - 58.8)
0.88
0.74 - 1.04
 
Occurrence of clinical malaria during the mission
     
0.0074
   No
2076
965
46.5 (35.2 - 57.8)
1
  
   Yes
17
2
11.8 (3.6 - 27.1)
0.18
0.05 - 0.63
 
N: Number of subjects; CC: Subjects with correct compliance
The variables retained in the final mixed multivariate logistic regression model are shown in Table 7. Correct compliance was significantly associated with the systematic use of one or more protective measures against mosquito bites, the perception of clinical malaria as potentially not severe or very severe (versus moderately severe), the birth of a child and the type of military operations (combat or training activities). Incorrect compliance was significantly associated with eveningness, a medical history of clinical malaria and a perceived mosquito attractiveness inferior or superior to the other soldiers. Compliance was not significantly associated with gender, age, rank or previous travels in malaria-endemic areas. The occurrence of clinical malaria during the mission was significantly associated with a lack of compliance as measured by the questionnaire (OR = 5.7, 95% CI: 1.6-20.2, p = 0.0074).
Table 7
Multivariate logistic regression analysis
 
N
N-CC
RE
   
aOR
IC 95%
p-value
Type of the mission
    
< 0.0001
   Training
703
140
1.00
  
   Military operation
1390
827
6.46
3.92 - 10.65
 
Preferred time for activities
    
0.0805
   Morning type
531
252
1.00
  
   Intermediate type
1248
585
0.83
0.65 - 1.05
 
   Evening type
314
530
0.69
0.50 - 0.96
 
Bedtime during the mission
    
< 0.0001
   Before or at midnight
1607
778
1.00
  
   After midnight
342
138
0.73
0.56 - 0.96
 
   Not Available (Company 1)
144
51
0.30
0.17 - 0.52
 
Birth of a child
    
0.0421
   No
2040
941
1.00
  
   Yes
53
26
1.99
1.02 - 3.88
 
Perception of the severity of malaria
    
0.0171
   Not severe
254
136
1.44
1.06 - 1.96
 
   Mildly severe
1473
654
1.00
  
   Very severe
366
177
1.31
1.00 - 1.71
 
Systematic use of protective measures: long clothes, repellents, and bed net
    
0.0001
   No one
653
249
1.00
  
   One of them
671
277
1.39
1.03 - 1.87
 
   Two or three of them
769
441
2.12
1.49 - 3.01
 
Medical history of clinical malaria
    
< 0.0001
   No
1870
902
1.00
  
   Yes
180
50
0.45
0.30 - 0.66
 
   Does not know
43
15
0.44
0.22 - 0.87
 
Perceived mosquito attractiveness, compared to other soldiers
    
0.0029
   Inferior to the others
608
275
0.71
0.56 - 0.89
 
   Equivalent to the others
998
490
1.00
  
   Superior to the others
487
202
0.71
0.55 - 0.91
 
Random effect (i.e. company effect)
    
< 0.0001
N: Number of subjects; CC: Subjects with correct compliance; NA: Not Available
aOR: adjusted OR; RE: Random Effect Model
There was no significant interaction between independent variables. The company effect was significant in the final model. The OR estimates were similar for both the random effect and GEE regression models.

Discussion

Many studies have been conducted in order to identify factors that influence compliance with medications, most of which focused on treatments to cure, reduce or delay complications and symptoms caused by chronic diseases. Only a few studies have assessed compliance in the context of chemoprophylaxis. Recently, the concept of adherence has supplanted compliance, as adherence implies that the patient agrees with the prescribed recommendations rather than passively obeying them (World Health Organization, 2003) [34]. However, in the present study, the concept of compliance was more suitable in the particular context of mandatory prophylactic measures. This work identified both collective and individual determinants of correct compliance with malaria chemoprophylaxis among French soldiers serving a short-term mission in intertropical Africa.

Individual factors

The systematic use of protective measures against mosquito bites (including long-sleeved clothes and pants, repellents and bed net) was associated with correct compliance with chemoprophylaxis. Whereas previous studies showed no association [28] or even a competition [35] between the use of prophylactic measures, the present study showed that those who stated compliance with chemoprophylaxis also stated compliance with anti-mosquito measures, suggesting common determinants of these prophylactic behaviors.
Among life events, only the birth of a child during the mission was associated with correct compliance. This could be explained by an increase in the level of responsibility felt towards the newborn, a greater maturity among those in a position to father a child or internal pressure from the family [23, 36], any of which could lead to a better awareness of the danger of malaria.
The "morning-type" soldiers, as determined by both the reduced Horne and Östberg morningness-eveningness questionnaire and by sleep/wake hours during the mission, were more likely to have correct compliance. Similarly, "evening-type" soldiers were less compliant with chemoprophylaxis. Eveningness has been associated with certain personality traits and dimensions (such as novelty-seeking, impulsivity, independent behaviour, risk taking, anti-conformism, lack of persistence and extraversion) [3739] and is linked to both genetic factors [40] and environment [41]. Furthermore, morning-types are known to have a healthier lifestyle [42, 43]. Thus, eveningness appears to be a risk factor for lack of compliance with malaria chemoprophylaxis, and it could be considered a target for focused interventions.
It has been shown that travellers who perceived themselves at high risk of becoming ill with malaria after returning home [26] or travellers to high-risk malaria-endemic areas who had correct risk perceptions [28] were more often compliant with chemoprophylaxis. The present study showed that subjects who either had a high or a low perception of the potential severity of clinical malaria were more often compliant compared to those who perceived it as mildly severe. This unexpected significant association persisted after adjusting for the other covariates and was explained by no interaction. The high level of compliance among those having a "very severe" perception confirmed the previous results. On the other hand, the "not severe" perception could be a consequence of feeling protected by one's correct compliance with an effective prophylactic measure. Indeed, perceptions and intentions must be considered together in behavioral studies [44].
Similarly, individuals who perceived themselves to be either more or less potent mosquito attractors than others were more compliant with chemoprophylaxis. This unexpected significant association also persisted after adjusting for the other covariates. Individuals who considered themselves less attractive to mosquitoes could be less compliant because of the perception of a lower risk of contracting malaria. In contrast, those who thought that they attracted mosquitoes more so than others were expected to be more compliant with anti-mosquito measures and could have believed that these anti-vectorial measures were sufficient to protect them. However, no significant interaction was found between the effects of the perceived mosquito attractiveness and compliance with anti-mosquito measures or chemoprophylaxis. Other determinants induced by the military setting such as fatalism or coping with danger by avoidance, denial or vulnerability could explain this unexpected association.
A previous medical history of malaria was associated with present lack of compliance. This suggests that having experienced an episode of clinical malaria was not a factor contributing by itself to the adoption of prophylactic behaviours [26]. Therefore, other arguments than the risk of contracting malaria should be used to convince these individuals to reach an optimal compliance with chemoprophylaxis.
The present study did not show any significant association between compliance and gender or age, although it has previously been shown that women and older travellers were more compliant [26, 35, 45]. However, the present work was conducted among French soldiers, where the proportion of women and older persons was small, leading to a lack of power to show such associations.

Collective factors

Military operation-type missions were associated with correct compliance, independent of the country or the army corps. In such conditions, the soldiers were probably more closely supervised by the command, so they were submitted to a higher pressure to comply with the chemoprophylaxis. Indeed, the good health of the soldiers, including the prevention of malaria, was an important concern of the command because of the operational nature of the mission: the global health of the group had to be preserved for a military purpose [46]. Compliance with malaria chemoprophylaxis was also better among civilian travellers who were taking part in an organized trip compared to those traveling independently [35].
After taking all these factors into account, there was still a significant group effect; that is, significant behaviour determinants associated with the companies that were not identified in the present study. Moreover, the rate of compliance was very heterogeneous among companies, meaning probably that individual behaviours were not independent within a company. This unconscious or conscious imitation was not explained by the previous determinants. The lack of isolated soldier limited the possibility of studying the group effect. Compliance with anti-malarial prevention measures appears to be the end result of a complex mixing of the perception of risks and of protective/curative interventions, the acceptance of these measures and their application in spite of discomfort; qualitative approaches could be appropriate for exploring these complexities [47].
In this study, the compliance was measured based on a self-administered questionnaire. This method could overestimate the rate of correct compliance, as previously shown for anti-viral therapy [48] or malaria chemoprophylaxis [45]. A preliminary study with an electronic device (MEMS®: Medication Event Monitoring System) that records the date and time of bottle cap opening has been conducted to objectively assess the rates of compliance in the first company. This electronic monitoring is considered to be more accurate than questionnaires, diaries or counts of returned untaken tablets for the assessment of compliance [49, 50]. If correct compliance is defined as 90% or more of daily prophylactic drug intake completed (using the MEMS® as the reference), the answers to the questionnaire used in the present study had a 0.69 and 0.75 sensitivity and specificity, respectively, to the assessment of the correct compliance. These quality indexes were close to those previously found by others using only one question [49, 51, 52]. The questionnaire used in the present study was then considered appropriate for investigation of compliance. Indeed, the occurrence of clinical malaria during the mission was strongly associated with compliance as estimated by the questionnaire.
The results of the present study are applicable to French soldiers travelling for a short-term mission in intertropical Africa because the companies were representative of the different malaria-endemic areas to which they could be sent. The prevalence of correct compliance with malaria chemoprophylaxis among soldiers was close to those reported elsewhere among civilian travellers [4, 28, 35], and several determinants of compliance were similar to those identified among civilian travellers as well. Even if all the results of the present study could not be directly extrapolated to civilian travellers, they are useful for identifying key factors to improve compliance with malaria chemoprophylaxis. Indeed, the present study conducted on a large sample of travellers has shown collective and individual factors, including a priori determinants likeeveningness, which are associated with compliance. The identification of circumstances and profiles of persons at higher risk of lack of compliance would allow the implementation of specifically targeted strategies of health information, education, and communication, in order to improve compliance with malaria chemoprophylaxis and therefore its effectiveness.

Acknowledgements

The authors are grateful to all the soldiers who agreed to participate in the study and to the commanding officers and the physicians of the companies for their warm acceptance. We also thank those who worked on the "Impact - Vector" project and participated in the collection of the data. We thank Dr C. Dane for her irreplaceable support. Financial support from French Ministry of Defense (Programme Impact - Vector - grant 02CO011, no. 010808 from the Délégation Générale pour l'Armement).
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://​creativecommons.​org/​licenses/​by/​2.​0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

NR performed the statistical analysis and wrote the article. VM participated significantly in the data management. LO, EOP and GT participated significantly in the data management and the conception of the questionnaires. JG participated in the statistical analysis. BP, CTT and AB contributed significantly in the preparation of the study. CR conceived the study, took part in the analysis of the data and the discussion and wrote the article. The final version of the manuscript was seen and approved by all authors.
Literatur
1.
Zurück zum Zitat Leder K, Black J, O'Brien D, Greenwood Z, Kain KC, Schwartz E, Brown G, Torresi J: Malaria in travelers: a review of the GeoSentinel surveillance network. Clin Infect Dis. 2004, 39: 1104-1112. 10.1086/424510.CrossRefPubMed Leder K, Black J, O'Brien D, Greenwood Z, Kain KC, Schwartz E, Brown G, Torresi J: Malaria in travelers: a review of the GeoSentinel surveillance network. Clin Infect Dis. 2004, 39: 1104-1112. 10.1086/424510.CrossRefPubMed
2.
Zurück zum Zitat Behrens RH, Carroll B, Smith V, Alexander N: Declining incidence of malaria imported into the UK from West Africa. Malar J. 2008, 7: 235-10.1186/1475-2875-7-235.PubMedCentralCrossRefPubMed Behrens RH, Carroll B, Smith V, Alexander N: Declining incidence of malaria imported into the UK from West Africa. Malar J. 2008, 7: 235-10.1186/1475-2875-7-235.PubMedCentralCrossRefPubMed
4.
Zurück zum Zitat Malvy D, Pistone T, Rezvani A, Lancon F, Vatan R, Receveur MC, Durand I, Hercberg S, El Hasnaoui A: Risk of malaria among French adult travellers. Travel Med Infect Dis. 2006, 4: 259-269. 10.1016/j.tmaid.2005.07.002.CrossRefPubMed Malvy D, Pistone T, Rezvani A, Lancon F, Vatan R, Receveur MC, Durand I, Hercberg S, El Hasnaoui A: Risk of malaria among French adult travellers. Travel Med Infect Dis. 2006, 4: 259-269. 10.1016/j.tmaid.2005.07.002.CrossRefPubMed
5.
Zurück zum Zitat Machault V, Orlandi-Pradines E, Michel R, Pages F, Texier G, Pradines B, Fusai T, Boutin JP, Rogier C: Remote sensing and malaria risk for military personnel in Africa. J Travel Med. 2008, 15: 216-220. 10.1111/j.1708-8305.2008.00202.x.CrossRefPubMed Machault V, Orlandi-Pradines E, Michel R, Pages F, Texier G, Pradines B, Fusai T, Boutin JP, Rogier C: Remote sensing and malaria risk for military personnel in Africa. J Travel Med. 2008, 15: 216-220. 10.1111/j.1708-8305.2008.00202.x.CrossRefPubMed
6.
Zurück zum Zitat Henry M, Diallo I, Bordes J, Ka S, Pradines B, Diatta B, M'Baye PS, Sane M, Thiam M, Gueye PM, Wade B, Touze JE, Debonne JM, Rogier C, Fusai T: Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates. Am J Trop Med Hyg. 2006, 75: 146-151.PubMed Henry M, Diallo I, Bordes J, Ka S, Pradines B, Diatta B, M'Baye PS, Sane M, Thiam M, Gueye PM, Wade B, Touze JE, Debonne JM, Rogier C, Fusai T: Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates. Am J Trop Med Hyg. 2006, 75: 146-151.PubMed
7.
Zurück zum Zitat Pradines B, Hovette P, Fusai T, Atanda HL, Baret E, Cheval P, Mosnier J, Callec A, Cren J, Amalvict R, Gardair JP, Rogier C: Prevalence of in vitro resistance to eleven standard or new antimalarial drugs among Plasmodium falciparum isolates from Pointe-Noire, Republic of the Congo. J Clin Microbiol. 2006, 44: 2404-2408. 10.1128/JCM.00623-06.PubMedCentralCrossRefPubMed Pradines B, Hovette P, Fusai T, Atanda HL, Baret E, Cheval P, Mosnier J, Callec A, Cren J, Amalvict R, Gardair JP, Rogier C: Prevalence of in vitro resistance to eleven standard or new antimalarial drugs among Plasmodium falciparum isolates from Pointe-Noire, Republic of the Congo. J Clin Microbiol. 2006, 44: 2404-2408. 10.1128/JCM.00623-06.PubMedCentralCrossRefPubMed
8.
Zurück zum Zitat Ciminera P, Brundage J: Malaria in U.S. military forces: a description of deployment exposures from 2003 through 2005. Am J Trop Med Hyg. 2007, 76: 275-279.PubMed Ciminera P, Brundage J: Malaria in U.S. military forces: a description of deployment exposures from 2003 through 2005. Am J Trop Med Hyg. 2007, 76: 275-279.PubMed
9.
Zurück zum Zitat Kotwal RS, Wenzel RB, Sterling RA, Porter WD, Jordan NN, Petruccelli BP: An outbreak of malaria in US Army Rangers returning from Afghanistan. JAMA. 2005, 293: 212-216. 10.1001/jama.293.2.212.CrossRefPubMed Kotwal RS, Wenzel RB, Sterling RA, Porter WD, Jordan NN, Petruccelli BP: An outbreak of malaria in US Army Rangers returning from Afghanistan. JAMA. 2005, 293: 212-216. 10.1001/jama.293.2.212.CrossRefPubMed
10.
Zurück zum Zitat Muentener P, Schlagenhauf P, Steffen R: Imported malaria (1985-95): trends and perspectives. Bull World Health Organ. 1999, 77: 560-566.PubMedCentralPubMed Muentener P, Schlagenhauf P, Steffen R: Imported malaria (1985-95): trends and perspectives. Bull World Health Organ. 1999, 77: 560-566.PubMedCentralPubMed
11.
Zurück zum Zitat Tuck JJ, Green AD, Roberts KI: A malaria outbreak following a British military deployment to Sierra Leone. J Infect. 2003, 47: 225-230. 10.1016/S0163-4453(03)00063-X.CrossRefPubMed Tuck JJ, Green AD, Roberts KI: A malaria outbreak following a British military deployment to Sierra Leone. J Infect. 2003, 47: 225-230. 10.1016/S0163-4453(03)00063-X.CrossRefPubMed
12.
Zurück zum Zitat Legros F, Bouchaud O, Ancelle T, Arnaud A, Cojean S, Le Bras J, Danis M, Fontanet A, Durand R: Risk factors for imported fatal Plasmodium falciparum malaria, France, 1996-2003. Emerg Infect Dis. 2007, 13: 883-888.CrossRefPubMed Legros F, Bouchaud O, Ancelle T, Arnaud A, Cojean S, Le Bras J, Danis M, Fontanet A, Durand R: Risk factors for imported fatal Plasmodium falciparum malaria, France, 1996-2003. Emerg Infect Dis. 2007, 13: 883-888.CrossRefPubMed
13.
Zurück zum Zitat Mali S, Steele S, Slutsker L, Arguin PM: Malaria surveillance--United States, 2006. MMWR Surveill Summ. 2008, 57: 24-39.PubMed Mali S, Steele S, Slutsker L, Arguin PM: Malaria surveillance--United States, 2006. MMWR Surveill Summ. 2008, 57: 24-39.PubMed
14.
Zurück zum Zitat Michel R, Ollivier L, Meynard JB, Guette C, Migliani R, Boutin JP: Outbreak of malaria among policemen in French Guiana. Mil Med. 2007, 172: 977-981.CrossRefPubMed Michel R, Ollivier L, Meynard JB, Guette C, Migliani R, Boutin JP: Outbreak of malaria among policemen in French Guiana. Mil Med. 2007, 172: 977-981.CrossRefPubMed
15.
Zurück zum Zitat Migliani R, Josse R, Hovette P, Keundjian A, Pages F, Meynard JB, Ollivier L, Sbai Idrissi K, Tifratene K, Orlandi E, Rogier C, Boutin JP: Malaria in military personnel: the case of the Ivory Coast in 2002-2003. Med Trop (Mars). 2003, 63: 282-286. Migliani R, Josse R, Hovette P, Keundjian A, Pages F, Meynard JB, Ollivier L, Sbai Idrissi K, Tifratene K, Orlandi E, Rogier C, Boutin JP: Malaria in military personnel: the case of the Ivory Coast in 2002-2003. Med Trop (Mars). 2003, 63: 282-286.
16.
Zurück zum Zitat Ollivier L, Michel R, Carlotti MP, Mahe P, Romand O, Todesco A, Migliani R, Boutin JP: Chemoprophylaxis compliance in a French battalion after returning from malaria-endemic area. J Travel Med. 2008, 15: 355-357. 10.1111/j.1708-8305.2008.00219.x.CrossRefPubMed Ollivier L, Michel R, Carlotti MP, Mahe P, Romand O, Todesco A, Migliani R, Boutin JP: Chemoprophylaxis compliance in a French battalion after returning from malaria-endemic area. J Travel Med. 2008, 15: 355-357. 10.1111/j.1708-8305.2008.00219.x.CrossRefPubMed
17.
Zurück zum Zitat Gordillo V, del Amo J, Soriano V, Gonzalez-Lahoz J: Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999, 13: 1763-1769. 10.1097/00002030-199909100-00021.CrossRefPubMed Gordillo V, del Amo J, Soriano V, Gonzalez-Lahoz J: Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999, 13: 1763-1769. 10.1097/00002030-199909100-00021.CrossRefPubMed
18.
Zurück zum Zitat Ines SM, Moralejo L, Marcos M, Fuertes A, Luna G: Adherence to highly active antiretroviral therapy in HIV-infected inmates. Curr HIV Res. 2008, 6: 164-170. 10.2174/157016208783885047.CrossRefPubMed Ines SM, Moralejo L, Marcos M, Fuertes A, Luna G: Adherence to highly active antiretroviral therapy in HIV-infected inmates. Curr HIV Res. 2008, 6: 164-170. 10.2174/157016208783885047.CrossRefPubMed
19.
Zurück zum Zitat Bezie Y, Molina M, Hernandez N, Batista R, Niang S, Huet D: Therapeutic compliance: a prospective analysis of various factors involved in the adherence rate in type 2 diabetes. Diabetes Metab. 2006, 32: 611-616. 10.1016/S1262-3636(07)70316-6.CrossRefPubMed Bezie Y, Molina M, Hernandez N, Batista R, Niang S, Huet D: Therapeutic compliance: a prospective analysis of various factors involved in the adherence rate in type 2 diabetes. Diabetes Metab. 2006, 32: 611-616. 10.1016/S1262-3636(07)70316-6.CrossRefPubMed
20.
Zurück zum Zitat Kyngas H: Compliance of adolescents with diabetes. J Pediatr Nurs. 2000, 15: 260-267. 10.1053/jpdn.2000.6169.CrossRefPubMed Kyngas H: Compliance of adolescents with diabetes. J Pediatr Nurs. 2000, 15: 260-267. 10.1053/jpdn.2000.6169.CrossRefPubMed
21.
Zurück zum Zitat Bordenave-Gabriel C, Giraud-Baro E, De Beauchamp I, Bougerol T, Calop J: Why psychotic patients are not drug compliant?. Encephale. 2003, 29: 213-222.PubMed Bordenave-Gabriel C, Giraud-Baro E, De Beauchamp I, Bougerol T, Calop J: Why psychotic patients are not drug compliant?. Encephale. 2003, 29: 213-222.PubMed
22.
Zurück zum Zitat Kampman O, Laippala P, Vaananen J, Koivisto E, Kiviniemi P, Kilkku N, Lehtinen K: Indicators of medication compliance in first-episode psychosis. Psychiatry Res. 2002, 110: 39-48. 10.1016/S0165-1781(02)00030-6.CrossRefPubMed Kampman O, Laippala P, Vaananen J, Koivisto E, Kiviniemi P, Kilkku N, Lehtinen K: Indicators of medication compliance in first-episode psychosis. Psychiatry Res. 2002, 110: 39-48. 10.1016/S0165-1781(02)00030-6.CrossRefPubMed
23.
Zurück zum Zitat Caceres Fde M, Orozco LC: Incidence of and factors for non-compliance to antituberculous treatment. Biomedica. 2007, 27: 498-504.CrossRefPubMed Caceres Fde M, Orozco LC: Incidence of and factors for non-compliance to antituberculous treatment. Biomedica. 2007, 27: 498-504.CrossRefPubMed
24.
Zurück zum Zitat Kaona FA, Tuba M, Siziya S, Sikaona L: An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health. 2004, 4: 68-10.1186/1471-2458-4-68.PubMedCentralCrossRefPubMed Kaona FA, Tuba M, Siziya S, Sikaona L: An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health. 2004, 4: 68-10.1186/1471-2458-4-68.PubMedCentralCrossRefPubMed
25.
Zurück zum Zitat Farquharson L, Noble LM, Barker C, Behrens RH: Health beliefs and communication in the travel clinic consultation as predictors of adherence to malaria chemoprophylaxis. Br J Health Psychol. 2004, 9: 201-217. 10.1348/135910704773891050.CrossRefPubMed Farquharson L, Noble LM, Barker C, Behrens RH: Health beliefs and communication in the travel clinic consultation as predictors of adherence to malaria chemoprophylaxis. Br J Health Psychol. 2004, 9: 201-217. 10.1348/135910704773891050.CrossRefPubMed
26.
Zurück zum Zitat Laver SM, Wetzels J, Behrens RH: Knowledge of malaria, risk perception, and compliance with prophylaxis and personal and environmental preventive measures in travelers exiting Zimbabwe from Harare and Victoria Falls International airport. J Travel Med. 2001, 8: 298-303.CrossRefPubMed Laver SM, Wetzels J, Behrens RH: Knowledge of malaria, risk perception, and compliance with prophylaxis and personal and environmental preventive measures in travelers exiting Zimbabwe from Harare and Victoria Falls International airport. J Travel Med. 2001, 8: 298-303.CrossRefPubMed
27.
Zurück zum Zitat Pistone T, Guibert P, Gay F, Malvy D, Ezzedine K, Receveur MC, Siriwardana M, Larouze B, Bouchaud O: Malaria risk perception, knowledge and prophylaxis practices among travellers of African ethnicity living in Paris and visiting their country of origin in sub-Saharan Africa. Trans R Soc Trop Med Hyg. 2007, 101: 990-995. 10.1016/j.trstmh.2007.05.009.CrossRefPubMed Pistone T, Guibert P, Gay F, Malvy D, Ezzedine K, Receveur MC, Siriwardana M, Larouze B, Bouchaud O: Malaria risk perception, knowledge and prophylaxis practices among travellers of African ethnicity living in Paris and visiting their country of origin in sub-Saharan Africa. Trans R Soc Trop Med Hyg. 2007, 101: 990-995. 10.1016/j.trstmh.2007.05.009.CrossRefPubMed
28.
Zurück zum Zitat Ropers G, Du Ry van Beest Holle M, Wichmann O, Kappelmayer L, Stuben U, Schonfeld C, Stark K: Determinants of malaria prophylaxis among German travelers to Kenya, Senegal, and Thailand. J Travel Med. 2008, 15: 162-171. 10.1111/j.1708-8305.2008.00188.x.CrossRefPubMed Ropers G, Du Ry van Beest Holle M, Wichmann O, Kappelmayer L, Stuben U, Schonfeld C, Stark K: Determinants of malaria prophylaxis among German travelers to Kenya, Senegal, and Thailand. J Travel Med. 2008, 15: 162-171. 10.1111/j.1708-8305.2008.00188.x.CrossRefPubMed
29.
Zurück zum Zitat Adan A, Almirall H: Horne & Östber morningness-eveningness questionnaire: a reduced scale. Personality and Individual differences. 1991, 12: 241-253. 10.1016/0191-8869(91)90110-W.CrossRef Adan A, Almirall H: Horne & Östber morningness-eveningness questionnaire: a reduced scale. Personality and Individual differences. 1991, 12: 241-253. 10.1016/0191-8869(91)90110-W.CrossRef
30.
Zurück zum Zitat Adan A, Almirall H: The influence of age, work schedule and personality on morningness dimension. Int J Psychophysiol. 1992, 12: 95-99. 10.1016/0167-8760(92)90001-R.CrossRefPubMed Adan A, Almirall H: The influence of age, work schedule and personality on morningness dimension. Int J Psychophysiol. 1992, 12: 95-99. 10.1016/0167-8760(92)90001-R.CrossRefPubMed
31.
Zurück zum Zitat Horne JA, Ostberg O: A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol. 1976, 4: 97-110.PubMed Horne JA, Ostberg O: A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol. 1976, 4: 97-110.PubMed
32.
Zurück zum Zitat Hu FB, Goldberg J, Hedeker D, Flay BR, Pentz MA: Comparison of population-averaged and subject-specific approaches for analyzing repeated binary outcomes. Am J Epidemiol. 1998, 147: 694-703.CrossRefPubMed Hu FB, Goldberg J, Hedeker D, Flay BR, Pentz MA: Comparison of population-averaged and subject-specific approaches for analyzing repeated binary outcomes. Am J Epidemiol. 1998, 147: 694-703.CrossRefPubMed
33.
Zurück zum Zitat Mickey RM, Greenland S: The impact of confounder selection criteria on effect estimation. Am J Epidemiol. 1989, 129: 125-137.PubMed Mickey RM, Greenland S: The impact of confounder selection criteria on effect estimation. Am J Epidemiol. 1989, 129: 125-137.PubMed
34.
Zurück zum Zitat Bissonnette JM: Adherence: a concept analysis. J Adv Nurs. 2008, 63: 634-643. 10.1111/j.1365-2648.2008.04745.x.CrossRefPubMed Bissonnette JM: Adherence: a concept analysis. J Adv Nurs. 2008, 63: 634-643. 10.1111/j.1365-2648.2008.04745.x.CrossRefPubMed
35.
Zurück zum Zitat Cobelens FG, Leentvaar-Kuijpers A: Compliance with malaria chemoprophylaxis and preventative measures against mosquito bites among Dutch travellers. Trop Med Int Health. 1997, 2: 705-713. 10.1046/j.1365-3156.1997.d01-357.x.CrossRefPubMed Cobelens FG, Leentvaar-Kuijpers A: Compliance with malaria chemoprophylaxis and preventative measures against mosquito bites among Dutch travellers. Trop Med Int Health. 1997, 2: 705-713. 10.1046/j.1365-3156.1997.d01-357.x.CrossRefPubMed
36.
Zurück zum Zitat Marin-Reyes F, Rodriguez-Moran M: Family support of treatment compliance in essential arterial hypertension. Salud Publica Mex. 2001, 43: 336-339.CrossRefPubMed Marin-Reyes F, Rodriguez-Moran M: Family support of treatment compliance in essential arterial hypertension. Salud Publica Mex. 2001, 43: 336-339.CrossRefPubMed
37.
Zurück zum Zitat Caci H, Robert P, Boyer P: Novelty seekers and impulsive subjects are low in morningness. Eur Psychiatry. 2004, 19: 79-84. 10.1016/j.eurpsy.2003.09.007.CrossRefPubMed Caci H, Robert P, Boyer P: Novelty seekers and impulsive subjects are low in morningness. Eur Psychiatry. 2004, 19: 79-84. 10.1016/j.eurpsy.2003.09.007.CrossRefPubMed
38.
Zurück zum Zitat Diaz-Morales J: Morning and evening-types: Exploring their personality styles. Pers Individ Dif. 2007, 43: 769-778. 10.1016/j.paid.2007.02.002.CrossRef Diaz-Morales J: Morning and evening-types: Exploring their personality styles. Pers Individ Dif. 2007, 43: 769-778. 10.1016/j.paid.2007.02.002.CrossRef
39.
Zurück zum Zitat Matthews G: Morningness-eveningness as a dimension of personality: trait, state and psychological correlates. European Journal of Personality. 1988, 2: 277-293. 10.1002/per.2410020405.CrossRef Matthews G: Morningness-eveningness as a dimension of personality: trait, state and psychological correlates. European Journal of Personality. 1988, 2: 277-293. 10.1002/per.2410020405.CrossRef
40.
Zurück zum Zitat Drennan MD, Shelby, D.F J, Kripke DF, Kelsoe J, Gillin JC: Morningness/eveningness is heritable. Soc Neurosci . 1992, 18: 196- Drennan MD, Shelby, D.F J, Kripke DF, Kelsoe J, Gillin JC: Morningness/eveningness is heritable. Soc Neurosci . 1992, 18: 196-
41.
Zurück zum Zitat Hur YM, Bourchard TJ, Lykken DT: Genetic and environnemental influence on morningness-eveningness. Personality and Individual differences . 1998, 25: 917-925. 10.1016/S0191-8869(98)00089-0.CrossRef Hur YM, Bourchard TJ, Lykken DT: Genetic and environnemental influence on morningness-eveningness. Personality and Individual differences . 1998, 25: 917-925. 10.1016/S0191-8869(98)00089-0.CrossRef
42.
Zurück zum Zitat Chelminski I, Ferraro FR, Petros TV, Plaud JJ: An analysis of the "eveningness-morningness" dimension in "depressive" college students. J Affect Disord. 1999, 52: 19-29. 10.1016/S0165-0327(98)00051-2.CrossRefPubMed Chelminski I, Ferraro FR, Petros TV, Plaud JJ: An analysis of the "eveningness-morningness" dimension in "depressive" college students. J Affect Disord. 1999, 52: 19-29. 10.1016/S0165-0327(98)00051-2.CrossRefPubMed
43.
Zurück zum Zitat Taillard J, Philip P, Chastang JF, Diefenbach K, Bioulac B: Is self-reported morbidity related to the circadian clock?. J Biol Rhythms. 2001, 16: 183-190. 10.1177/074873001129001764.CrossRefPubMed Taillard J, Philip P, Chastang JF, Diefenbach K, Bioulac B: Is self-reported morbidity related to the circadian clock?. J Biol Rhythms. 2001, 16: 183-190. 10.1177/074873001129001764.CrossRefPubMed
44.
Zurück zum Zitat Weinstein ND, Nicolich M: Correct and incorrect interpretations of correlations between risk perceptions and risk behaviors. Health Psychol. 1993, 12: 235-245. 10.1037/0278-6133.12.3.235.CrossRefPubMed Weinstein ND, Nicolich M: Correct and incorrect interpretations of correlations between risk perceptions and risk behaviors. Health Psychol. 1993, 12: 235-245. 10.1037/0278-6133.12.3.235.CrossRefPubMed
45.
Zurück zum Zitat Landry P, Iorillo D, Darioli R, Burnier M, Genton B: Do travelers really take their mefloquine malaria chemoprophylaxis? Estimation of adherence by an electronic pillbox. J Travel Med. 2006, 13: 8-14. 10.1111/j.1708-8305.2006.00005.x.CrossRefPubMed Landry P, Iorillo D, Darioli R, Burnier M, Genton B: Do travelers really take their mefloquine malaria chemoprophylaxis? Estimation of adherence by an electronic pillbox. J Travel Med. 2006, 13: 8-14. 10.1111/j.1708-8305.2006.00005.x.CrossRefPubMed
46.
Zurück zum Zitat Houston DJ, Tuck JJ: Malaria on a military peacekeeping operation: a case study with no cases. Mil Med. 2005, 170: 193-195.CrossRefPubMed Houston DJ, Tuck JJ: Malaria on a military peacekeeping operation: a case study with no cases. Mil Med. 2005, 170: 193-195.CrossRefPubMed
47.
Zurück zum Zitat Kruse W: Patient compliance with drug treatment--new perspectives on an old problem. Clin Investig. 1992, 70: 163-166. 10.1007/BF00227361.CrossRefPubMed Kruse W: Patient compliance with drug treatment--new perspectives on an old problem. Clin Investig. 1992, 70: 163-166. 10.1007/BF00227361.CrossRefPubMed
48.
Zurück zum Zitat Arnsten JH, Demas PA, Farzadegan H, Grant RW, Gourevitch MN, Chang CJ, Buono D, Eckholdt H, Howard AA, Schoenbaum EE: Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis. 2001, 33: 1417-1423. 10.1086/323201.PubMedCentralCrossRefPubMed Arnsten JH, Demas PA, Farzadegan H, Grant RW, Gourevitch MN, Chang CJ, Buono D, Eckholdt H, Howard AA, Schoenbaum EE: Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis. 2001, 33: 1417-1423. 10.1086/323201.PubMedCentralCrossRefPubMed
49.
Zurück zum Zitat Liu H, Golin CE, Miller LG, Hays RD, Beck CK, Sanandaji S, Christian J, Maldonado T, Duran D, Kaplan AH, Wenger NS: A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001, 134: 968-977.CrossRefPubMed Liu H, Golin CE, Miller LG, Hays RD, Beck CK, Sanandaji S, Christian J, Maldonado T, Duran D, Kaplan AH, Wenger NS: A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001, 134: 968-977.CrossRefPubMed
50.
Zurück zum Zitat Remington G, Kwon J, Collins A, Laporte D, Mann S, Christensen B: The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia. Schizophr Res. 2007, 90: 229-237. 10.1016/j.schres.2006.11.015.CrossRefPubMed Remington G, Kwon J, Collins A, Laporte D, Mann S, Christensen B: The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia. Schizophr Res. 2007, 90: 229-237. 10.1016/j.schres.2006.11.015.CrossRefPubMed
51.
Zurück zum Zitat George CF, Peveler RC, Heiliger S, Thompson C: Compliance with tricyclic antidepressants: the value of four different methods of assessment. Br J Clin Pharmacol. 2000, 50: 166-171. 10.1046/j.1365-2125.2000.00244.x.PubMedCentralCrossRefPubMed George CF, Peveler RC, Heiliger S, Thompson C: Compliance with tricyclic antidepressants: the value of four different methods of assessment. Br J Clin Pharmacol. 2000, 50: 166-171. 10.1046/j.1365-2125.2000.00244.x.PubMedCentralCrossRefPubMed
52.
Zurück zum Zitat Zeller A, Schroeder K, Peters TJ: An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to antihypertensive treatment. J Clin Epidemiol. 2008, 61: 282-288. 10.1016/j.jclinepi.2007.04.007.CrossRefPubMed Zeller A, Schroeder K, Peters TJ: An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to antihypertensive treatment. J Clin Epidemiol. 2008, 61: 282-288. 10.1016/j.jclinepi.2007.04.007.CrossRefPubMed
Metadaten
Titel
Determinants of compliance with malaria chemoprophylaxis among French soldiers during missions in inter-tropical Africa
verfasst von
Noémie Resseguier
Vanessa Machault
Lénaick Ollivier
Eve Orlandi-Pradines
Gaetan Texier
Bruno Pradines
Jean Gaudart
Alain Buguet
Catherine Tourette-Turgis
Christophe Rogier
Publikationsdatum
01.12.2010
Verlag
BioMed Central
Erschienen in
Malaria Journal / Ausgabe 1/2010
Elektronische ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-9-41

Weitere Artikel der Ausgabe 1/2010

Malaria Journal 1/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.